Head-to-head · Value Score
CoreAge Rx vs Amble
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, Amble a 76. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$99/mo
Save ~89% vs brand-nameAmble
#109 · Grade B- · Fair Price
Est. first month
$179/mo month-to-month ($135/mo on a 12-month plan)
Save ~87% vs brand-nameThe verdict
CoreAge Rx takes it on Value Score, 93 to 76 — an est. $99/mo first month, with no teaser step-up baked in. Amble isn't out of it: Someone who wants a dose-independent rate and can decide up front how long to commit.
CoreAge Rx is also our overall #1 pick across the whole deals ranking — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | Amble |
|---|---|---|
| Value Score | 93 (A+) | 76 (B-) |
| Est. first month | $99/mo | $179/mo month-to-month ($135/mo on a 12-month plan) |
| Save vs brand-name | ~89% | ~87% |
| Semaglutide | $99/mo | $179/mo month-to-month ($135/mo on a 12-month plan) |
| Tirzepatide | $149/mo | From $289/mo (starting dose, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Flat — no step-up |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
Amble
Amble is a nationwide telehealth platform selling once-weekly compounded GLP-1 injections at a flat rate that does not move as your dose climbs, alongside NAD+, sermorelin and other longevity injections.
Why it's a deal
- The whole price ladder is published rather than quoted after an intake: $179 month-to-month, $160 on a 3-month plan, $145 on six months and $135 on twelve
- States plainly that the price is the same at every dose, so titrating up does not raise the bill
- Available in all 50 states, with medication, supplies and shipping bundled into the quoted rate and no separate membership fee
- Names both pharmacy types it uses and explains the difference — 503A licensed by state boards, 503B registered with the FDA — rather than saying only "licensed pharmacy"
- HSA and FSA eligible
The fine print
- The same-price-at-every-dose policy explicitly does not cover introductory or first-month offers, and the site runs one on its homepage, so the promotional figure is the one without the guarantee
- The cheapest rates need a long commitment paid as a block — $135 is a twelve-month decision, not a monthly one
- The homepage, the GLP-1 page and the banner quote three different entry figures ($179, $135 and $150), so which one applies depends on where you land
- It sells GLP-1s beside NAD+, sermorelin, glutathione and lipotropic injections, so the weight-loss program is one line in a broader longevity menu
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives ranking, and the same list for the other side is on alternatives to Amble.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.